BMY 14802 hydrochloride - CAS 105565-55-7
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C18H22F2N4O.HCl
Molecular Weight:
384.86
COA:
Inquire
Targets:
5-HT Receptor | Sigma Receptor
Description:
BMY 14802 hydrochloride is a potent sigma receptor antagonist (IC50 = 112 nM) with weak affinity for 5-HT1A and α1 receptors. BMY 14802 is potentially used as an atypical antipsychotic agent for schizophrenia treatment.
Brife Description:
sigma receptor antagonist
Purity:
≥98% by HPLC
Related CAS:
105565-56-8 (free base)
Synonyms:
BMS-181100 hydrochloride; BMY 14802 HCl; α-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol hydrochloride
MSDS:
Inquire
Application:
potential atypical antipsychotic agent
InChIKey:
NIBVEFRJDFVQLM-UHFFFAOYSA-N
InChI:
InChI=1S/C18H22F2N4O.ClH/c19-15-5-3-14(4-6-15)17(25)2-1-7-23-8-10-24(11-9-23)18-21-12-16(20)13-22-18;/h3-6,12-13,17,25H,1-2,7-11H2;1H
Canonical SMILES:
C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F.Cl
1.NPC 16377, a potent and selective sigma-ligand. II. Behavioral and neuroprotective profile.
Clissold DB1, Pontecorvo MJ, Jones BE, Abreu ME, Karbon EW, Erickson RH, Natalie KJ Jr, Borosky S, Hartman T, Mansbach RS, et al. J Pharmacol Exp Ther. 1993 May;265(2):876-86.
6-[6-(4-Hydroxypiperidinyl)hexyloxy]-3-methylflavone HCI, (NPC 16377), a potent and highly selective sigma-site ligand, was evaluated in tests predictive of antipsychotic and neuroprotective potential and for toxicity. Like haloperidol, clozapine and remoxipride, and the sigma-ligands BMY 14802, ifenprodil and rimcazole, NPC 16377 reversed amphetamine-induced hyperactivity and apomorphine-induced climbing in mice. Additional evidence for antipsychotic activity was obtained in rats with NPC 16377, clozapine, BMY 14802, ifenprodil, haloperidol and rimcazole, all of which reduced conditioned avoidance responses at doses that did not reduce escape behavior. NPC 16377 did not induce catalepsy in mice, suggesting a decreased liability for producing extrapyramidal side effects. NPC 16377 extended survival time for mice exposed to a hypoxic environment. In a model of global ischemia using conscious gerbils, NPC 16377 prevented damage to hippocampal CA1 neurons after either intraperitoneal or oral administration.
2.Regulation of [3H]dopamine release from rat striatal slices by sigma receptor ligands.
Gonzalez-Alvear GM1, Werling LL. J Pharmacol Exp Ther. 1994 Oct;271(1):212-9.
Sigma receptors have been located in several areas of the brain that control motor function, including on the dopaminergic projections from substantia nigra to striatum. In the current study, the regulation of N-methyl-D-aspartate-stimulated [3H]dopamine release from slices of rat striatum by several sigma ligands has been tested. Both isomers of the benzomorphans SKF10,047 and pentazocine inhibited the stimulated release of dopamine in a concentration-related manner. All these compounds probably activate sigma and non-sigma receptors, including phencyclidine receptors, over the broad concentration ranges tested. However, concentrations of (+)pentazocine below about 100 nM appear to act solely through sigma receptors. This phase of inhibition was reversed by the sigma antagonist N-[-2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-[1- pyrimidinyl-1-piperazine butanol and by the sigma1-selective antagonist (1-(cyclopropylmethyl)-4-2'4"-fluorophenyl)-(2'-oxoethyl)piperi din e HBr.
3.Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice.
Kim HW1, Kwon YB, Roh DH, Yoon SY, Han HJ, Kim KW, Beitz AJ, Lee JH. Br J Pharmacol. 2006 Jun;148(4):490-8. Epub 2006 May 8.
Although previous reports have suggested that the sigma 1 (sigma(1)) receptor may be involved in pain sensation, its specific site of action has not been elucidated. The aim of present study was to determine the role of the spinal sigma(1) receptor in formalin-induced pain behavior, spinal cord Fos expression and phosphorylation of N-methyl-D-aspartate receptor subunit 1 (pNR1). Intrathecal (i.t.) pretreatment with the selective sigma(1) receptor antagonist, BD-1047 (N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(dimethylamino)ethylamine dihydrobromide) (10-100 nmol) dose dependently reduced formalin-induced pain behaviors in second phase, but not first phase, of the formalin test. I.t. injection of BD-1047 also reduced formalin-evoked Fos expression and pNR1 at the protein kinase C-dependent site, serine-896 (Ser896) and the protein kinase A-dependent site, serine-897 (Ser897) in spinal dorsal horn.i.t. BMY-14802 ((alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol hydrochloride) (10-100 nmol, sigma(1) receptor antagonist and 5-HT(1A) receptor agonist) dose dependently reduced formalin-induced pain behaviors in both phases.
4.sigma Receptor antagonists block the development of sensitization to cocaine.
Ujike H1, Kuroda S, Otsuki S. Eur J Pharmacol. 1996 Jan 25;296(2):123-8.
The effects of putative sigma receptor antagonists, BMY-14802 (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine), rimcazole and SR-31742A (cis-3-(hexahydroazepin-1-yl)1-(3-chloro-4- cyclohexylphenyl)propene-1), on the development of behavioral sensitization induced by repeated administration of cocaine were investigated. Acute intraperitoneal injection of 15 mg/kg cocaine in rats induced moderate hyperactivity which mainly consisted of sniffing and rearing. These acute effects of cocaine were hardly affected by co-administration of the sigma receptor antagonists, except that BMY-14802 enhanced, but not significantly cocaine-induced locomotion. While repeated cocaine administration induced a progressive increase in stereotyped behaviors and resulted in sensitization, every sigma receptor antagonists tested attenuated the development of sensitization to cocaine. These prophylactic effects of sigma receptor antagonists against cocaine-induced sensitization were confirmed by the challenge test with cocaine alone after an abstinence.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related 5-HT Receptor Products


PR-073

PR-073 is a novel 5-HT7 antagonist, which can inhibit immune responses and treat inflammatory bowel disease (IBD). Preclinical studies demonstrated that PR-073 ...

CAS 878141-96-9 S1RA

S1RA
(CAS: 878141-96-9)

The sigma-1 (σ1) receptor is an intracellular, non-opioid receptor that is abundantly expressed in the central nervous system as well as peripherally. S1RA is a...

CAS 192927-92-7 LY310762

LY310762
(CAS: 192927-92-7)

LY310762 has a higher affinity for the guinea pig 5-HT1D receptor than for the 5-HT1B receptor. LY310762 potentiates the potassium-induced [3H]5-HT outflow from...

CAS 82752-99-6 Nefazodone hydrochloride

Nefazodone hydrochloride
(CAS: 82752-99-6)

Nefazodone hydrochloride is a selective serotonin 5-HT2 receptor antagonist. It is used as an antidepressant that shows no cardiac toxicity or anticholinergic a...

CAS 139290-65-6 MDL 100907

MDL 100907
(CAS: 139290-65-6)

MDL 100907 is a selective 5-HT2A receptor antagonist with Ki value of 0.36 nM. It shows antipsychotic activity, attenuates impulsivity, and augments antidepress...

CAS 1210-81-7 ST 1936 oxalate

ST 1936 oxalate
(CAS: 1210-81-7)

ST 1936 oxalate is a selective and high affinity agonist of 5-HT6 receptors (Ki = 13, 168, and 245 nM for human 5-HT6, 5-HT7 and 5-HT2B receptors, respectively)...

CAS 359625-79-9 CYR-101

CYR-101
(CAS: 359625-79-9)

MIN-101, a novel cyclic amide derivative, is a 5-HT2A and sigma 2 receptor antagonist (Ki= 7.53 nM for 5-HT2A and 8.19 nM for sigma-2, respectively).

CAS 139652-01-0 4H-1-Benzopyran-4-one, 6-[[6-(4-hydroxy-1-piperidinyl)hexyl]oxy]-3-methyl-2-phenyl-

4H-1-Benzopyran-4-one, 6-[[6-(4-hydroxy-
(CAS: 139652-01-0)

Sigma-LIGAND-1, also called as NPC 16377, is a selective sigma receptor ligand developed for the treatment of neurological disorders and psychotic disorders in ...

CAS 105565-55-7 BMY 14802 hydrochloride

BMY 14802 hydrochloride
(CAS: 105565-55-7)

BMY 14802 hydrochloride is a potent sigma receptor antagonist (IC50 = 112 nM) with weak affinity for 5-HT1A and α1 receptors. BMY 14802 is potentially used as a...

CAS 97-39-2 DTG

DTG
(CAS: 97-39-2)

DTG has been found to be a σ-receptor agonist and is useful in studies of its interaction with dopamine drug.

CAS 912342-28-0 TCB-2

TCB-2
(CAS: 912342-28-0)

TCB-2 is a high affinity 5-HT2A receptor agonist (Ki = 0.73 and 0.75 nM for rat and human receptors, respectively). TCB-2 stimulates IP3 accumulation in NIH3T3 ...

S1RA Hydrochloride
(CAS: 1265917-14-3)

The hydrochloride salt form of S1RA which is a σ1 receptor antagonist that has been found to have potential effect in pain therapy. It is still under Phase II c...

CAS 207455-21-8 L-693,403 maleate

L-693,403 maleate
(CAS: 207455-21-8)

L-693,403 maleate is the maleate salt of L-693,403, which is a sigma receptor-binding compound. It has excellent selectivity over the dopamine D2 receptor and b...

CAS 932736-91-9 (±)-PPCC oxalate

(±)-PPCC oxalate
(CAS: 932736-91-9)

(±)-PPCC oxalate is a selective sigma (σ) receptor ligand, which is noted to exhibit high affinity for σ1 and also binds at σ2 sites (Ki = 1.5 nM and 50.8 nM re...

CAS 97469-12-0 α-Methyl-5-hydroxytryptamine maleate

α-Methyl-5-hydroxytryptamine maleate
(CAS: 97469-12-0)

α-Methyl-5-hydroxytryptamine maleate, a salt of α-Methylserotonin maleate, is a 5-HT2B receptor selective agonist with pKi values of 8.4, 6.1 and 7.3 at 5-HT2B,...

CAS 123482-23-5 Zatosetron maleate

Zatosetron maleate
(CAS: 123482-23-5)

Zatosetron has been identified as a potent, orally available, long-acting, selective 5HT3 receptor antagonist, which is potentially useful in the treatment of c...

MK212 hydrochloride
(CAS: 61655-58-1)

MK212 hydrochloride is a selective 5-HT2C serotonin receptor agonist. It displays selectivity for 5-HT2C over 5-HT2A with IC50 values of 0.028 and 0.42 μM for h...

CAS 313984-77-9 PU 02

PU 02
(CAS: 313984-77-9)

PU 02 is a potent and selective 5-HT3 receptor antagonist (IC50 values are 0.36 and 0.73 μM in HEK293 cells transfected with human 5-HT3A and 5-HT3AB receptors ...

CAS 172907-03-8 PB 28 dihydrochloride

PB 28 dihydrochloride
(CAS: 172907-03-8)

PB 28 dihydrochloride is a high affinity σ2 receptor agonist. It displays antiproliferative and cytotoxic effects in SK-N-SH neuroblastoma and C6 glioma cells.

CAS 189188-57-6 Tegaserod maleate

Tegaserod maleate
(CAS: 189188-57-6)

Tegaserod maleate is a partial agonist of the 5-HT4 receptor (Ki = 12 nM) that can treat irritable bowel syndrome (IBS).

Chemical Structure

CAS 105565-55-7 BMY 14802 hydrochloride

Quick Inquiry

Verification code

Featured Items